Tea pigments inhibit the production of type 1 (TH1) and type 2 (TH2) helper T cell cytokines in CD4+ T cells

被引:28
作者
Tomita, M
Irwin, KI
Xie, ZJ
Santoro, TJ
机构
[1] Med Coll Ohio, Dept Med, Toledo, OH 43614 USA
[2] Med Coll Ohio, Dept Pharmacol, Toledo, OH 43614 USA
[3] Med Coll Ohio, Dept Physiol & Mol Med, Toledo, OH 43614 USA
关键词
tea pigments; theaflavins; NF kappa B; CD4(+) T cells; cytokines;
D O I
10.1002/ptr.834
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Tea pigments are oxidized products of polyphenols derived front tea leaves (Camellia sinensis). Theaflavins are constituents of tea pigments with antioxidant, antineoplastic and antiinflammatory properties similar to their parent compounds. The biological properties of polyphenols and theaflavins have been linked to their capacity to inhibit the activation of nuclear factor-kappaB (NF-kappaB), a transcription factor, which is critically involved in the molecular regulation of a number of proinflammatory cytokines. The current study examines the requirement for NF-kappaB in the immunosuppressive effects mediated by tea antioxidants. Specifically, we tested the hypothesis that cytokines produced by type 1 (T-H1) CD4(1) T cells which require NF-kappaB for gene expression, such as interleukin-2 (IL-2) and interferon gamma (IFN gamma), are selectively inhibited by tea pigments. We found that tea pigments potently suppress IL-2 secretion, IL-2 gene expression and the activation of NF-kappaB in murine spleens enriched for CD4(1) T cells, as expected. Consistent with our hypothesis, tea pigments also inhibited the induction of IFNgamma mRNA. However, the expression of the T-H2 cytokines IL-4 and IL-5, which lack functional NF-kappaB sites within their promoters was unexpectedly suppressed by tea pigments, as well. The results indicate that NF-kappaB may be only one of multiple transcription factors inhibited by tea pigments. Copyright (C) 2002 John Wiley and Sons, Ltd.
引用
收藏
页码:36 / 42
页数:7
相关论文
共 30 条
[1]  
Ahmad N, 1999, NUTR REV, V57, P78, DOI 10.1111/j.1753-4887.1999.tb06927.x
[2]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[3]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[4]  
Beauparlant Pierre, 1996, Cytokine and Growth Factor Reviews, V7, P175, DOI 10.1016/1359-6101(96)00020-2
[5]  
CAI XX, 1993, INVEST OPHTH VIS SCI, V34, P3585
[6]   Identification of a calcium-inducible, cyclosporine-sensitive element in the IFN-gamma promoter that is a potential NFAT binding site [J].
Campbell, PM ;
Pimm, J ;
Ramassar, V ;
Halloran, PF .
TRANSPLANTATION, 1996, 61 (06) :933-939
[7]   Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin [J].
Chen, YR ;
Tan, TH .
ONCOGENE, 1998, 17 (02) :173-178
[8]   At the crossroads of inflammation and tumorigenesis [J].
Cordon-Cardo, C ;
Prives, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) :1367-1370
[9]  
Dong ZG, 1997, CANCER RES, V57, P4414
[10]   NUCLEAR-ASSOCIATION OF A T-CELL TRANSCRIPTION FACTOR BLOCKED BY FK-506 AND CYCLOSPORINE-A [J].
FLANAGAN, WM ;
CORTHESY, B ;
BRAM, RJ ;
CRABTREE, GR .
NATURE, 1991, 352 (6338) :803-807